Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Dec. 31, 2024

Notes to Financial Statements

SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]

GEOVAX LABS, INC.

SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS

For the Years Ended December 31, 2024 and 2023

			Additions (Reductions)
Description	Balance at Beginning Of Period		Charged to Costs and Expenses		Charged to Other Accounts		Deductions		Balance at End Of Period
Reserve Deducted in the Balance Sheet From the Asset to Which it Applies:
Allowance for Deferred Tax Assets
Year ended December 31, 2024	$	29,935,162	$	6,848,610	$	-0-	$	-0-	$	36,783,772
Year ended December 31, 2023	$	22,909,470	$	7,025,692	$	-0-	$	-0-	$	29,935,162